Home › Research › Mild cognitive impairment
Using machine learning for detection of Parkinson’s disease and mild cognitive impairment
Anthaea-Grace Patricia Dennis, Sarah L. Martin, Robert E. Chen, Philip Gerretsen, Antonio P. Strafella. PLoS ONE, 2025-11-19
Topic: Risk, prevention and care in population studies
Overall, both machine learning techniques had an equivalent performance. In general, in those models for detecting Parkinson's disease, DaT-SPECT performed better than biofluid biomarkers. In models for detecting Parkinson's disease patients with mild cognitive impairment, combining DaT-SPECT with phosphorylated-tau-181 resulted in higher accuracy, outperforming DaT-SPECT alone. Classification for Parkinson's disease and mild cognitive impairment may be improved by combining neuroimaging with biofluid biomarkers through machine learning models.
Key findings
- Overall, both machine learning techniques had an equivalent performance.
- In general, in those models for detecting Parkinson's disease, DaT-SPECT performed better than biofluid biomarkers.
- In models for detecting Parkinson's disease patients with mild cognitive impairment, combining DaT-SPECT with phosphorylated-tau-181 resulted in higher accuracy, outperforming DaT-SPECT alone.
- Classification for Parkinson's disease and mild cognitive impairment may be improved by combining neuroimaging with biofluid biomarkers through machine learning models.
Why it matters
This work used machine learning to detect Parkinson's disease and mild cognitive impairment, finding that combining DaT-SPECT with phosphorylated-tau-181 improved accuracy over DaT-SPECT alone. It concerns classification and diagnosis rather than treating, curing or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (PLoS ONE) |
| Journal's citation record | 4 / 4 | PLoS ONE: journal h-index 594 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Antonio P. Strafella: h-index 73 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Toronto: institution h-index 1,923 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41259329) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Dennis, A.-G. P., Martin, S. L., Chen, R. E., Gerretsen, P., & Strafella, A. P. (2025). Using machine learning for detection of Parkinson’s disease and mild cognitive impairment. PLoS ONE. https://doi.org/10.1371/journal.pone.0335541
Vancouver
Dennis A.-GP, Martin SL, Chen RE, Gerretsen P, Strafella AP. Using machine learning for detection of Parkinson’s disease and mild cognitive impairment. PLoS ONE. 2025. doi:10.1371/journal.pone.0335541. PMID: 41259329.
BibTeX
@article{dennis2025-41259329,
author = {Dennis, Anthaea-Grace Patricia and Martin, Sarah L. and Chen, Robert E. and Gerretsen, Philip and Strafella, Antonio P.},
title = {{Using machine learning for detection of Parkinson’s disease and mild cognitive impairment}},
journal = {PLoS ONE},
year = {2025},
doi = {10.1371/journal.pone.0335541},
pmid = {41259329},
url = {https://doi.org/10.1371/journal.pone.0335541}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.